Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
A4300 GW96621 CitationSummary: PPARγ antagonist
-
A4302 Rosiglitazone maleateTarget: Insulin and Insulin-like ReceptorsSummary: PPARγ agonist,high-affinity and selective,potent insulin sensitizer
-
A4303 GSK3787Summary: PPARβ/δ antagonist,novel and irreversible
-
A4304 RosiglitazoneSummary: Potent PPARγ agonist
-
A4305 WY-14643 (Pirinixic Acid)1 CitationTarget: PPARSummary: PPARα agonist,selective and highly potent
-
A4309 GW5015161 CitationSummary: PPARδ agonist,selective and potent
-
A4324 Pioglitazone HClSummary: PPARγ agonist
-
B2117 PioglitazoneSummary: PPAR agonist
-
B1943 Fenofibrate1 CitationSummary: PPARα agonist
-
B7010 15-deoxy-Δ-12,14-Prostaglandin J2Target: PPARSummary: PPARγ agonist